Role of radiotherapy in the treatment of EGFR-mutant non-small-cell lung cancer: a narrative review
Therapeutic Advances in Medical Oncology
Published online on April 18, 2026
Abstract
Therapeutic Advances in Medical Oncology, Volume 18, January-December 2026.
The emergence of targeted therapies, such as epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase inhibitors, has marked a new chapter in the management of non-small-cell lung cancer (NSCLC). However, monotherapy with targeted agents ...
The emergence of targeted therapies, such as epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase inhibitors, has marked a new chapter in the management of non-small-cell lung cancer (NSCLC). However, monotherapy with targeted agents ...